+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

P-Akt expression distinguishes two types of malignant rhabdoid tumors



P-Akt expression distinguishes two types of malignant rhabdoid tumors



Journal of Cellular Physiology 209(2): 422-427



Highly aggressive pediatric malignant rhabdoid tumors (MRT) arise in the kidney and central nervous system (CNS) with no curative treatment available. Multiple studies have shown that inactivation of the SNF5 tumor suppressor gene occurs in virtually all MRTs. However, few studies have addressed whether additional genetic events may contribute to MRT development. In this report, we demonstrate that phosphorylated Akt (P-Akt) is expressed in a subpopulation of cells in at least 10% of primary rhabdoid tumors as well as at high levels in three MRT cell lines. Similar to other high P-Akt expressing tumor cell lines, MRTs have decreased sensitivity to p21 induced growth arrest. Therefore, P-Akt expression may distinguish between two types of MRTs. Because drugs directed against the PI3-K/Akt have shown promise in clinical trials for other tumor types, they may prove useful for treatment of patients with P-Akt positive MRTs. P-Akt expression also provides a potential mechanistic link between these pediatric tumors and adult malignancies.

(PDF emailed within 0-6 h: $19.90)

Accession: 049839808

Download citation: RISBibTeXText

PMID: 16897758

DOI: 10.1002/jcp.20737


Related references

Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. American Journal of Surgical Pathology 28(11): 1485-1491, 2004

Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosomes & Cancer 34(1): 33-41, 2002

High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro-Oncology 13(12): 1296-1307, 2012

Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. American Journal of Surgical Pathology 30(11): 1462-1468, 2006

Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?. Cancer Genetics 207(9): 384-389, 2015

Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). Child's Nervous System 29(11): 1977-1983, 2014

Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors. Journal of Neuro-Oncology 74(3): 311-319, 2005

Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Pediatric and Developmental Pathology 14(5): 353-359, 2012

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins. American Journal of Surgical Pathology 35(10): 1463-1472, 2011

The immunohistochemical pattern of mucin expression distinguishes between different types of intraductal papillary mucinous tumors of the pancreas and determines their relationship to ductal adenocarcinoma. Pathology Research & Practice 197(5): 368, 2001

INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. Journal of Neuropathology and Experimental Neurology 64(5): 391-397, 2005

Histopathologic diagnostic and histogenetic problems in malignant soft tissue tumors. Reassessment of malignant fibrous histiocytoma, epithelioid sarcoma, malignant rhabdoid tumor, and neuroectodermal tumor. Acta Pathologica Japonica 42(10): 691-706, 1992

The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Research 62(1): 323-328, 2002